UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061647
Receipt number R000070391
Scientific Title Association between postoperative drain tip position and postoperative epidural hematoma and decompression findings after full-endoscopic unilateral laminotomy for bilateral decompression: a prospective observational study
Date of disclosure of the study information 2026/05/21
Last modified on 2026/05/21 12:43:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective study of the relationship between drain position and postoperative hematoma and decompression status after full-endoscopic lumbar decompression

Acronym

FESS-Drain Study

Scientific Title

Association between postoperative drain tip position and postoperative epidural hematoma and decompression findings after full-endoscopic unilateral laminotomy for bilateral decompression: a prospective observational study

Scientific Title:Acronym

FESS-Drain Study

Region

Japan


Condition

Condition

lumbar spinal canal stenosis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify whether drain tip position assessed by CT 1-2 days after full-endoscopic unilateral laminotomy for bilateral decompression is associated with the amount and severity of postoperative epidural hematoma/fluid collection and decompression parameters assessed by MRI 3-4 days postoperatively, thereby informing optimization of postoperative management.

Basic objectives2

Others

Basic objectives -Others

Postoperative imaging evaluation

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Association between the drain tip position grade assessed by CT 1-2 days postoperatively and the epidural hematoma/fluid collection occupancy rate (%) and hematoma severity grade (0-3) assessed by MRI 3-4 days postoperatively.

Key secondary outcomes

1. Drainage volume (total and by time interval).
2. Dural sac cross-sectional area (DSCSA) at postoperative day 3 and 6 months, and changes in DSCSA.
3. Clinical events up to 30 days postoperatively, including symptomatic hematoma, reoperation, and readmission.
4. Associations between imaging findings and patient-reported outcome measures at 3, 6, and 12 months postoperatively, including VAS, ODI, and JOA scores.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who meet all of the following criteria will be included.
1. Patients undergoing full-endoscopic unilateral laminotomy for bilateral decompression for lumbar spinal canal stenosis, mainly degenerative disease, at our institution.
2. Age at surgery 20 years or older.
3. Patients undergoing CT at 1-2 days postoperatively, MRI at 3-4 days postoperatively, and MRI at 6 months postoperatively according to the clinical pathway at our institution.

Key exclusion criteria

Patients meeting any of the following criteria will be excluded.
1. Patients whose main pathology is other than lumbar spinal canal stenosis, such as tumor, infection, trauma, or inflammatory disease.
2. Patients undergoing concomitant fusion or instrumentation.
3. Patients who cannot undergo postoperative MRI because of contraindications or other reasons.
4. Patients who refuse participation in the study through the opt-out process.
5. Patients judged by the principal investigator to be unsuitable for the study, such as cases in which imaging evaluation is technically difficult.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Shota
Middle name
Last name Takenaka

Organization

Japan Community Healthcare Organization Osaka Hospital

Division name

Department of orthopaedic surgery

Zip code

553-0003

Address

4-2-78 Fukushima, Fukushima-ku, Osaka City, Osaka, Japan

TEL

0664415451

Email

show@yb3.so-net.ne.jp


Public contact

Name of contact person

1st name Shota
Middle name
Last name Takenaka

Organization

Japan Community Healthcare Organization Osaka Hospital

Division name

Department of orthopaedic surgery

Zip code

553-0003

Address

4-2-78 Fukushima, Fukushima-ku, Osaka City, Osaka, Japan

TEL

0664415451

Homepage URL


Email

show@yb3.so-net.ne.jp


Sponsor or person

Institute

Japan Community Healthcare Organization Osaka Hospital

Institute

Department

Personal name



Funding Source

Organization

self funnding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Community Healthcare Organization Osaka Hospital Review Board

Address

4-2-78 Fukushima, Fukushima-ku, Osaka City, Osaka, Japan

Tel

06-6441-5451

Email

horimoto-takiko@osaka.jcho.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 05 Month 10 Day

Date of IRB

2026 Year 05 Month 21 Day

Anticipated trial start date

2026 Year 05 Month 21 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study design: Single-center prospective observational study.
Recruitment: Consecutive patients undergoing full-endoscopic unilateral laminotomy for bilateral decompression (FESS-ULBD) for lumbar spinal stenosis.
Units: Registration: patient. Analysis: patient, surgery, or decompressed level as prespecified.
Sampling: Consecutive.
Main predictor: Drain tip position grade on CT at POD1-2.
Main outcomes: Epidural hematoma/fluid collection occupancy rate (%) and hematoma grade (0-3) on MRI at POD3-4.
Drain management: A 3.5-mm SB bag (Sumitomo Bakelite) with suction adjusted so the balloon contacts the wall.
Data collection:
- Patient factors: age, sex, BMI, comorbidities, anticoagulant/antiplatelet use.
- Surgical data: diagnosis, surgery date, procedure, level, decompression extent, operative time, blood loss.
- Drain data: tip position, drainage volume (total and interval), timing of removal.
- Imaging: preoperative MRI; CT POD1-2; MRI POD3-4 and 6 months; radiographs as needed. CT will assess drain tip position; MRI will assess hematoma/fluid collection and decompression status.
- Clinical course: events within 30 days, including symptomatic hematoma, reoperation, readmission.
- PROMs: VAS, ODI, JOA, and routine-care measures at 3, 6, and 12 months.
Statistical analysis: Descriptive statistics for baseline, surgical, drain, and imaging variables. Primary analysis will evaluate associations between drain tip position grade and hematoma occupancy rate or hematoma grade on POD3-4 MRI using mixed-effects models, ordinal logistic regression, or other appropriate models accounting for within-patient correlation. Secondary analyses will examine associations with drainage volume, DSCSA, and PROMs.


Management information

Registered date

2026 Year 05 Month 21 Day

Last modified on

2026 Year 05 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070391